SightfileU.S. market data from official filings

ORASURE TECHNOLOGIES INC (OSUR)

Name: ORASURE TECHNOLOGIES INC (OSUR) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001116463 · EDGAR filings · Updated 2026-06-30

ORASURE TECHNOLOGIES INC (OSUR) has reported institutional ownership of 82.4%, with 141 institutional managers holding positions valued at $169.9M per the latest 13F reporting period.

Institutional ownership

82.4%

Institutional managers

141

Reported 13F value

$169.9M

Insider activity

39 trans.

$326.4K net buying

Latest updates

2026-06-30 — Insider transaction reported (Form 4)
2026-06-11 — Current report (8-K) filed
2026-06-05 — Insider transaction reported (Form 4)
2026-06-05 — Insider transaction reported (Form 4)
2026-06-05 — Insider transaction reported (Form 4)
2026-06-05 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, ORASURE TECHNOLOGIES INC has 141 institutional holders and institutional ownership of 82.4%.

Insider activity

Insiders reported 39 transactions (5 buys, 0 sells) across 10 reporting insiders, with a net reported value of $326.4K.

Related companies

ABEONA THERAPEUTICS INC (ABEO) · LINEAGE CELL THERAPEUTICS IN (LCTX) · CAMP4 THERAPEUTICS CORP (CAMP) · PULSE BIOSCIENCES INC (PLSE) · NIAGEN BIOSCIENCE INC (NAGE) · EUPRAXIA PHARMACEUTICALS INC (EPRX)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-30.